We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Blood Glucose Monitoring System Clinical Study (BGMS)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01327209
First Posted: April 1, 2011
Last Update Posted: June 9, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Intuity Medical, Inc
March 30, 2011
April 1, 2011
June 9, 2011
December 2010
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT01327209 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Blood Glucose Monitoring System Clinical Study
Blood Glucose Monitoring System Clinical Study

Verify the following with blood glucose monitoring system:

  • precision and accuracy versus YSI reference
  • user evaluation
  • labeling comprehension
Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
People who have been diagnosed with diabetes and are testing their blood glucose level at least once per day.
Diabetes
Not Provided
Patients with diabetes
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
202
April 2011
Not Provided

Inclusion Criteria:

  • Be diagnosed with Diabetes
  • Be between 12 and 70 years of age
  • Be able to read, write, and understand English
  • Be able and willing to give Informed Consent
  • Have used an SMBG meter system for at least one year
  • Be currently testing blood glucose levels at least once per day

Exclusion Criteria:

  • Inability to provide Informed Consent
  • Subject does not meet Inclusion Criteria
  • Subject does not agree to test for infectious diseases per clinical protocol
  • Subject has minimally one positive test for any infectious disease listed under Exclusion Criteria per protocol
  • Subject with any condition (in addition to those which are listed in the pre-screen Exclusion Criteria tests) which in the opinion of the Investigator may place the subject or site personnel at excessive risk
  • Subject's physical condition/limitation prevents the person from using a BGMS on their own
Sexes Eligible for Study: All
12 Years to 70 Years   (Child, Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01327209
TP-0000145
No
Not Provided
Not Provided
Dr. Richard Bergenstal, International Diabetes Center
Intuity Medical, Inc
Not Provided
Principal Investigator: Richard Bergenstal, MD Park Nicollett Institue - International Diabetes Center
Intuity Medical, Inc
June 2011